Healthcare -
Biotechnology - NASDAQ - US
$ 0.4
-42.8 %
$ 145 M
Market Cap
-0.54
P/E
LXRX - COMMON STOCK REPURCHASED
Common Stock Repurchased LXRX - Lexicon Pharmaceuticals, Inc.
-824 K
LAST VALUE
44.50%
2 YEAR CAGR
3.25%
5 YEAR CAGR
0.58%
10 YEAR CAGR